CEBPA and intrahepatic cholangiocarcinoma: Recent studies demonstrated that CEBPA mutations involving bZIP region were associated with favorable prognosis in both biallelic and single mutations.2,8,9 The favorable category in the new ICC of myeloid neoplasms and acute leukemia10 has been updated to CEBPA with inframe bZIP mutations instead of biallelic mutations.